← All Sponsors
SPONSOR

Shantou Central Hospital

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Breast Cancer
NCT05728268 Phase 2
Recruiting

Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index

Breast Cancer
China View Trial →